Evidence map›Paper›PMID 38285061›Full record

ArticleNanoscale2024

Magnetic coagulometry: towards a new nanotechnological tool for

Antonio Santana-Otero, Alan Harper, Neil Telling, Daniel Ortega, David Cabrera

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanoscale, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Antonio Santana-OteroCondensed Matter Physics Department, Faculty of Sciences, University of Cádiz, Campus Universitario Rio San Pedro s/n, 11510 Puerto Real, Cádiz, Spain. daniel.ortega@uca.es.ORCID http://orcid.org/0000-0002-2204-4093
Alan HarperSchool of Medicine, Keele University, Newcastle-under-Lyme, Staffordshire. ST5 5BG, UK.ORCID http://orcid.org/0000-0003-2413-4823
Neil TellingSchool of Pharmacy and Bioengineering, Keele University, Guy Hilton Research Centre, Thronburrow Drive, Hartshill, Stoke on Trent, ST47QB, UK. d.c.cabrera@keele.ac.uk.ORCID http://orcid.org/0000-0002-2683-5546
Daniel OrtegaCondensed Matter Physics Department, Faculty of Sciences, University of Cádiz, Campus Universitario Rio San Pedro s/n, 11510 Puerto Real, Cádiz, Spain. daniel.ortega@uca.es.ORCID http://orcid.org/0000-0002-7441-8640
David CabreraSchool of Pharmacy and Bioengineering, Keele University, Guy Hilton Research Centre, Thronburrow Drive, Hartshill, Stoke on Trent, ST47QB, UK. d.c.cabrera@keele.ac.uk.ORCID http://orcid.org/0000-0001-7912-9939
Keele University · GBMadrid Institute for Advanced Studies · ESUniversidad de Cádiz · ES

Funding

Wellcome Trust
6 · The paper itself

Abstract

Blood clotting disorders consisting of unwanted blood clot formation or excessive bleeding are some of the main causes of death worldwide. However, there are significant limitations in the current methods used to clinically monitor the dynamics of clot formation in human whole blood

Indexed as

Blood CoagulationThrombosisBlood Coagulation TestsHumansMagnetic PhenomenaProthrombin Time

Identifiers

PMID38285061
PMCPMC10868660
OpenAlexW4390085812

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.